Loading…
CIK 0001856083 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("deep-track-capital-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC | COM | $35.0M | 0.6% | 9,345,000 SH | New |
| ALIGOS THERAPEUTICS INC | COM NEW | $3.3M | 0.1%Prev: 0.1% | 444,110 SH | Decreased |
| ALKERMES PLC | SHS | $127.0M | 2.1% | 3,590,323 SH | New |
| ALUMIS INC | COM | $149.2M | 2.4% | 6,772,595 SH | New |
| ANI PHARMACEUTICALS INC | COM | $46.1M | 0.8%Prev: 1.5% | 600,000 SH | Decreased-100,000 SH |
| APELLIS PHARMACEUTICALS INC | COM | $182.3M | 3.0%Prev: 3.5% | 4,532,374 SH | Increased-467,626 SH |
| APOGEE THERAPEUTICS INC | COM | $24.0M | 0.4% | 285,000 SH | New |
| ATAIBECKLEY INC | COM SHS | $42.5M | 0.7% | 12,000,000 SH | New |
| AXSOME THERAPEUTICS INC. | COM | $185.9M | 3.0% | 1,100,000 SH | New |
| BEAM THERAPEUTICS INC | COM | $19.6M | 0.3%Prev: 0.2% | 820,765 SH | Increased+505,000 SH |
| BICARA THERAPEUTICS INC | COM | $80.8M | 1.3%Prev: 0.8% | 4,062,500 SH | Increased+2,062,500 SH |
| BILLIONTOONE INC | CL A | $3.9M | 0.1% | 50,000 SH | New |
| BIOMARIN PHARMACEUTICAL INC | COM | $65.0M | 1.1% | 1,150,000 SH | New |
| BRIDGEBIO PHARMA INC | COM | $62.5M | 1.0%Prev: 3.1% | 841,445 SH | Decreased-1,958,555 SH |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $40.7M | 0.7%Prev: 1.2% | 1,283,979 SH | Increased-716,021 SH |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $125.4M | 2.0% | 3,158,041 SH | New |
| CENTURY THERAPEUTICS INC | COM | $21.4M | 0.4% | 9,487,745 SH | New |
| COGENT BIOSCIENCES INC | COM | $38.5M | 0.6% | 1,000,000 SH | New |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $67.3M | 1.1%Prev: 0.8% | 12,161,496 SH | Increased+3,301,848 SH |
| CONTEXT THERAPEUTICS INC | COM | $19.4M | 0.3%Prev: 0.1% | 7,419,355 SH | Increased |
| CORMEDIX INC | COM | $42.6M | 0.7% | 6,274,076 SH | New |
| CORVUS PHARMACEUTICALS INC | COM | $36.5M | 0.6% | 2,491,539 SH | New |
| CRESCENT BIOPHARMA INC. | COM | $8.3M | 0.1% | 453,686 SH | New |
| CYBIN INC | COM NEW | $6.3M | 0.1%Prev: 0.3% | 1,313,137 SH | Decreased-216,850 SH |
| CYTOKINETICS INC | COM NEW | $90.6M | 1.5%Prev: 4.0% | 1,374,320 SH | Decreased-1,699,533 SH |
| DEFINIUM THERAPEUTICS INC | COM SHS | $56.7M | 0.9% | 3,000,000 SH | New |
| DYNE THERAPEUTICS INC | COM | $36.3M | 0.6%Prev: 0.7% | 2,000,000 SH | Increased |
| ENANTA PHARMACEUTICALS INC | COM | $24.7M | 0.4% | 1,956,867 SH | New |
| ENGENE HOLDINGS INC | COM | $29.8M | 0.5%Prev: 0.7% | 4,377,572 SH | Increased-180,003 SH |
| GENMAB A/S | SPONSORED ADS | $98.3M | 1.6% | 3,663,250 SH | New |
| GERON CORP | COM | $47.3M | 0.8%Prev: 2.0% | 31,720,278 SH | Decreased-6,455,973 SH |
| GRAIL INC | COM | $89.0M | 1.5% | 1,722,797 SH | New |
| GUARDANT HEALTH INC | COM | $308.4M | 5.0%Prev: 7.5% | 3,338,241 SH | Increased-2,105,480 SH |
| IMMUNOCORE HLDGS PLC | ADS | $58.2M | 1.0%Prev: 1.4% | 1,931,884 SH | Increased+520,482 SH |
| IMMUNOVANT INC | COM | $286.3M | 4.7%Prev: 5.3% | 11,526,971 SH | Increased+2,026,971 SH |
| INVENTIVA SA | ADS | $6.8M | 0.1% | 1,222,453 SH | New |
| IONIS PHARMACEUTICALS INC | COM | $146.4M | 2.4%Prev: 4.5% | 1,950,000 SH | Increased-2,614,207 SH |
| JANUX THERAPEUTICS INC | COM | $16.5M | 0.3% | 1,187,290 SH | New |
| KURA ONCOLOGY INC | COM | $21.5M | 0.4% | 2,643,542 SH | New |
| LARIMAR THERAPEUTICS INC | COM | $6.8M | 0.1% | 1,500,000 SH | New |
| LB PHARMACEUTICALS INC | COM SHS | $82.7M | 1.4% | 3,352,804 SH | New |
| MAZE THERAPEUTICS INC | COM | $103.8M | 1.7%Prev: 1.2% | 3,477,562 SH | Increased+208,436 SH |
| MBX BIOSCIENCES INC | COM | $82.3M | 1.3%Prev: 0.7% | 2,757,569 SH | Increased-261,366 SH |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $119.5M | 2.0% | 6,408,863 SH | New |
| NURIX THERAPEUTICS INC | COM | $98.4M | 1.6%Prev: 2.1% | 6,345,244 SH | Increased+845,244 SH |
| NUVALENT INC | COM | $141.0M | 2.3% | 1,376,324 SH | New |
| OCULAR THERAPEUTIX INC | COM | $166.7M | 2.7%Prev: 3.4% | 19,686,282 SH | Increased+5,391,862 SH |
| ORUKA THERAPEUTICS INC | COM | $99.8M | 1.6%Prev: 0.5% | 2,034,203 SH | Increased+589,494 SH |
| PERSONALIS INC | COM | $19.1M | 0.3% | 3,000,000 SH | New |
| PROMIS NEUROSCIENCES INC | COM SHS | $10.6M | 0.2% | 835,655 SH | New |
| SOLENO THERAPEUTICS INC | COM | $36.1M | 0.6% | 1,078,710 SH | New |
| SOLID BIOSCIENCES INC | COM NEW | $25.7M | 0.4% | 3,565,062 SH | New |
| SPDR SERIES TRUST | STATE STREET SPD | $1.28B | 20.9% | 10,000,000 SH | New |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $206.3M | 3.4%Prev: 2.3% | 4,279,848 SH | Increased+179,848 SH |
| TANGO THERAPEUTICS INC | COM | $57.5M | 0.9% | 2,750,000 SH | New |
| TARSUS PHARMACEUTICALS INC | COM | $252.5M | 4.1%Prev: 2.5% | 3,600,000 SH | Increased+2,115,734 SH |
| TERNS PHARMACEUTICALS INC | COM | $56.6M | 0.9%Prev: 0.5% | 1,073,877 SH | Increased-4,502,681 SH |
| VAXCYTE INC | COM | $249.9M | 4.1%Prev: 0.9% | 4,300,000 SH | Increased+3,550,000 SH |
| VERA THERAPEUTICS INC | CL A | $165.2M | 2.7% | 4,106,067 SH | New |
| VERADERMICS INC | COMMON STOCK | $31.6M | 0.5% | 500,000 SH | New |
| VERASTEM INC | COM NEW | $30.4M | 0.5% | 5,740,850 SH | New |
| VIRIDIAN THERAPEUTICS INC | COM | $27.3M | 0.4%Prev: 2.3% | 1,393,944 SH | Decreased-3,986,505 SH |
| X4 PHARMACEUTICALS INC | COM NEW | $26.2M | 0.4% | 6,339,535 SH | New |
| 13F-HR |
| 0001856083-26-000004 |
| $6.87B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001856083-25-000004 | $3.12B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001856083-26-000003 | $6.12B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001856083-25-000002 | $3.09B | View |